Form 4: TD SYNNEX Director Sells Shares Via Pre-Arranged Plan

Sentiment:

Insider Transaction Report


TD SYNNEX Director Merline Saintil sold 167 shares of common stock for $157.75 per share on March 4, 2026, as part of a pre-arranged trading plan.

Summary

  • Merline Saintil, a Director of TD SYNNEX CORP [SNX], reported a sale of common stock.
  • The transaction involved the disposition of 167 shares of common stock.
  • The shares were sold at a price of $157.75 per share.
  • The sale occurred on March 4, 2026.
  • Following this transaction, Merline Saintil directly beneficially owns 6,995 shares of TD SYNNEX common stock.
  • The sale was executed pursuant to a Rule 10b5-1 trading plan adopted on August 2, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was pre-scheduled under a 10b5-1 plan, indicating a planned liquidity event rather than a reaction to new company-specific information.

Industry Context

StockSavvy.ai notes that sales executed under a Rule 10b5-1 plan are pre-scheduled and typically do not reflect new discretionary sentiment from the insider regarding the company's immediate prospects, distinguishing them from open market, discretionary sales.

Stakeholder Impact

  • Shareholders: The sale represents a minor reduction in a director's direct ownership, which is a routine event under a pre-arranged plan and is unlikely to have a significant impact on shareholder sentiment or company valuation.

Key Dates

DateDescription
2025-08-02Adoption date of the Rule 10b5-1 trading plan.
2026-03-04Date of common stock transaction.
2026-03-05Date the Form 4 was signed.

Recommendation

hold

The reported transaction is a routine insider sale executed under a Rule 10b5-1 trading plan, which was adopted several months prior to the sale date. This type of transaction is generally not indicative of a change in the company's fundamental outlook or the insider's confidence, but rather a pre-planned liquidity event. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

TD SYNNEX, SNX, Merline Saintil, Director, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Common Stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.